Anti-PIK3R1 antibody-conjugated liposomes represent a promising strategy in glioma treatment by specifically targeting tumor cells that overexpress the PIK3R1 receptor. By leveraging receptor-mediated endocytosis, these specialized liposomes can enhance drug delivery efficiency, ensuring that therapeutic agents are more effectively internalized by the cancer cells. This targeted approach not only improves the overall efficacy of the treatment but also minimizes potential side effects associated with systemic drug administration, offering a more precise and effective therapeutic option for glioma patients.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-2711 | Hi-Affi™ Recombinant Rabbit Anti-PIK3R1 Monoclonal Antibody (DS2711AB) | WB, IHC, ICC, FC, IP | IgG |
There are currently no Customer reviews or questions for VS-1024-FY123. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.